Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 87
  2. 88
  3. 89
  4. 90
  5. 91
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Cixutumumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5144-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Cixutumumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5144-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Cixutumumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5144-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Cixutumumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5144-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Cixutumumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5144-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Efalizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5145-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Efalizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5145-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Efalizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5145-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Efalizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5145-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Efalizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5145-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Efalizumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5145-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Eldelumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5146-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Eldelumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5146-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Eldelumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5146-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Eldelumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5146-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Eldelumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5146-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Eldelumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5146-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Emapalumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5147-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Emapalumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5147-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Emapalumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5147-10mg

IchorBio 		10 mg Anmelden
Vergleichen
Emapalumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5147-20mg

IchorBio 		20 mg Anmelden
Vergleichen
Emapalumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5147-50mg

IchorBio 		50 mg Anmelden
Vergleichen
Emapalumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5147-100mg

IchorBio 		100 mg Anmelden
Vergleichen
Emibetuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5148-1mg

IchorBio 		1 mg Anmelden
Vergleichen
Emibetuzumab Biosimilar -­ Research Grade Produkt-Datenblatt downloaden Biosimilars Hu FA ICH5148-5mg

IchorBio 		5 mg Anmelden
Vergleichen
Name Preis
Cixutumumab Biosimilar -­ Research Grade Anmelden Cixutumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Cixutumumab Biosimilar -­ Research Grade Anmelden Cixutumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Cixutumumab Biosimilar -­ Research Grade Anmelden Cixutumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Cixutumumab Biosimilar -­ Research Grade Anmelden Cixutumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Cixutumumab Biosimilar -­ Research Grade Anmelden Cixutumumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Efalizumab Biosimilar -­ Research Grade Anmelden Efalizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Efalizumab Biosimilar -­ Research Grade Anmelden Efalizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Efalizumab Biosimilar -­ Research Grade Anmelden Efalizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Efalizumab Biosimilar -­ Research Grade Anmelden Efalizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Efalizumab Biosimilar -­ Research Grade Anmelden Efalizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Efalizumab Biosimilar -­ Research Grade Anmelden Efalizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Eldelumab Biosimilar -­ Research Grade Anmelden Eldelumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Eldelumab Biosimilar -­ Research Grade Anmelden Eldelumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Eldelumab Biosimilar -­ Research Grade Anmelden Eldelumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Eldelumab Biosimilar -­ Research Grade Anmelden Eldelumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Eldelumab Biosimilar -­ Research Grade Anmelden Eldelumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Eldelumab Biosimilar -­ Research Grade Anmelden Eldelumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Emapalumab Biosimilar -­ Research Grade Anmelden Emapalumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Emapalumab Biosimilar -­ Research Grade Anmelden Emapalumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar
Emapalumab Biosimilar -­ Research Grade Anmelden Emapalumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 10 mg
Lieferbar
Emapalumab Biosimilar -­ Research Grade Anmelden Emapalumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 20 mg
Lieferbar
Emapalumab Biosimilar -­ Research Grade Anmelden Emapalumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 50 mg
Lieferbar
Emapalumab Biosimilar -­ Research Grade Anmelden Emapalumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 100 mg
Lieferbar
Emibetuzumab Biosimilar -­ Research Grade Anmelden Emibetuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 1 mg
Lieferbar
Emibetuzumab Biosimilar -­ Research Grade Anmelden Emibetuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl. FA
Host
ArtNr.
Menge 5 mg
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 87
  2. 88
  3. 89
  4. 90
  5. 91
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top